Cargando…
Recent Developments in the Use of Intralesional Injections Keloid Treatment
Keloid scars are often considered aesthetically unattractive and frustrating problems that occur following injuries. They cause functional and cosmetic deformities, displeasure, itching, pain, and psychological stress and possibly affect joint movement. The combination of these factors ultimately re...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Plastic and Reconstructive Surgeons
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4228202/ https://www.ncbi.nlm.nih.gov/pubmed/25396172 http://dx.doi.org/10.5999/aps.2014.41.6.620 |
_version_ | 1782343932369174528 |
---|---|
author | Trisliana Perdanasari, Aurelia Lazzeri, Davide Su, Weijie Xi, Wenjing Zheng, Zhang Ke, Li Min, Peiru Feng, Shaoqing Zhang, Yi Xin Persichetti, Paolo |
author_facet | Trisliana Perdanasari, Aurelia Lazzeri, Davide Su, Weijie Xi, Wenjing Zheng, Zhang Ke, Li Min, Peiru Feng, Shaoqing Zhang, Yi Xin Persichetti, Paolo |
author_sort | Trisliana Perdanasari, Aurelia |
collection | PubMed |
description | Keloid scars are often considered aesthetically unattractive and frustrating problems that occur following injuries. They cause functional and cosmetic deformities, displeasure, itching, pain, and psychological stress and possibly affect joint movement. The combination of these factors ultimately results in a compromised quality of life and diminished functional performance. Various methods have been implemented to improve keloid scars using both surgical and non-surgical approaches. However, it has proven to be a challenge to identify a universal treatment that can deliver optimal results for all types of scars. Through a PubMed search, we explored most of the literature that is available about the intralesional injection treatment of hypertrophic scars and keloids and highlights both current (corticosteroid, 5-fluorouracil, bleomycin, interferon, cryotherapy and verapamil) and future treatments (interleukin-10 and botulinum toxin type A). The reference lists of retrieved articles were also analysed. Information was gathered about the mechanism of each injection treatment, its benefits and associated adverse reactions, and possible strategies to address adverse reactions to provide reliable guidelines for determining the optimal treatment for particular types of keloid scars. This article will benefit practitioners by outlining evidence-based treatment strategies using intralesional injections for patients with hypertrophic scars and keloids. |
format | Online Article Text |
id | pubmed-4228202 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | The Korean Society of Plastic and Reconstructive Surgeons |
record_format | MEDLINE/PubMed |
spelling | pubmed-42282022014-11-13 Recent Developments in the Use of Intralesional Injections Keloid Treatment Trisliana Perdanasari, Aurelia Lazzeri, Davide Su, Weijie Xi, Wenjing Zheng, Zhang Ke, Li Min, Peiru Feng, Shaoqing Zhang, Yi Xin Persichetti, Paolo Arch Plast Surg Review Article Keloid scars are often considered aesthetically unattractive and frustrating problems that occur following injuries. They cause functional and cosmetic deformities, displeasure, itching, pain, and psychological stress and possibly affect joint movement. The combination of these factors ultimately results in a compromised quality of life and diminished functional performance. Various methods have been implemented to improve keloid scars using both surgical and non-surgical approaches. However, it has proven to be a challenge to identify a universal treatment that can deliver optimal results for all types of scars. Through a PubMed search, we explored most of the literature that is available about the intralesional injection treatment of hypertrophic scars and keloids and highlights both current (corticosteroid, 5-fluorouracil, bleomycin, interferon, cryotherapy and verapamil) and future treatments (interleukin-10 and botulinum toxin type A). The reference lists of retrieved articles were also analysed. Information was gathered about the mechanism of each injection treatment, its benefits and associated adverse reactions, and possible strategies to address adverse reactions to provide reliable guidelines for determining the optimal treatment for particular types of keloid scars. This article will benefit practitioners by outlining evidence-based treatment strategies using intralesional injections for patients with hypertrophic scars and keloids. The Korean Society of Plastic and Reconstructive Surgeons 2014-11 2014-11-03 /pmc/articles/PMC4228202/ /pubmed/25396172 http://dx.doi.org/10.5999/aps.2014.41.6.620 Text en Copyright © 2014 The Korean Society of Plastic and Reconstructive Surgeons http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Trisliana Perdanasari, Aurelia Lazzeri, Davide Su, Weijie Xi, Wenjing Zheng, Zhang Ke, Li Min, Peiru Feng, Shaoqing Zhang, Yi Xin Persichetti, Paolo Recent Developments in the Use of Intralesional Injections Keloid Treatment |
title | Recent Developments in the Use of Intralesional Injections Keloid Treatment |
title_full | Recent Developments in the Use of Intralesional Injections Keloid Treatment |
title_fullStr | Recent Developments in the Use of Intralesional Injections Keloid Treatment |
title_full_unstemmed | Recent Developments in the Use of Intralesional Injections Keloid Treatment |
title_short | Recent Developments in the Use of Intralesional Injections Keloid Treatment |
title_sort | recent developments in the use of intralesional injections keloid treatment |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4228202/ https://www.ncbi.nlm.nih.gov/pubmed/25396172 http://dx.doi.org/10.5999/aps.2014.41.6.620 |
work_keys_str_mv | AT trislianaperdanasariaurelia recentdevelopmentsintheuseofintralesionalinjectionskeloidtreatment AT lazzeridavide recentdevelopmentsintheuseofintralesionalinjectionskeloidtreatment AT suweijie recentdevelopmentsintheuseofintralesionalinjectionskeloidtreatment AT xiwenjing recentdevelopmentsintheuseofintralesionalinjectionskeloidtreatment AT zhengzhang recentdevelopmentsintheuseofintralesionalinjectionskeloidtreatment AT keli recentdevelopmentsintheuseofintralesionalinjectionskeloidtreatment AT minpeiru recentdevelopmentsintheuseofintralesionalinjectionskeloidtreatment AT fengshaoqing recentdevelopmentsintheuseofintralesionalinjectionskeloidtreatment AT zhangyixin recentdevelopmentsintheuseofintralesionalinjectionskeloidtreatment AT persichettipaolo recentdevelopmentsintheuseofintralesionalinjectionskeloidtreatment |